FDA approves Biogen's MS drug Plegridy
Biogen Idec says that federal regulators have approved the specialty drugmaker's new treatment for people with relapsing forms of multiple sclerosis.
Aug 16, 2014
0
0
Biogen Idec says that federal regulators have approved the specialty drugmaker's new treatment for people with relapsing forms of multiple sclerosis.
Aug 16, 2014
0
0
Neurologist Dr. Matthew Tremblay, who specializes in the care of patients with multiple sclerosis at UConn Health, discusses the first drug just approved by the FDA for patients with difficult to treat primary progressive ...
Mar 31, 2017
0
5
Taiwanese investigators have found that there can be a significantly higher risk of multiple sclerosis (MS) occurring in the year following a shingles, or herpes zoster, attack. The findings, which support a long-held view ...
Jun 8, 2011
0
0
(Medical Xpress)—New treatments for inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, diabetes and autism could be on the horizon, after a global University of Melbourne – lead study successfully mapped ...
Jun 16, 2014
0
0
People living with multiple sclerosis have the dice loaded against them when it comes to their decision-making ability as their neurological disease progresses, according to a new study from the University of Alberta's Faculty ...
Jul 8, 2015
0
49
A commonly-prescribed multiple sclerosis (MS) infusion medication linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to a new study led by MS specialists NYU Langone Health.
Feb 3, 2018
0
34
(Medical Xpress)—Imagine that your mechanic tells you that your brake pads seem thin, but doesn't know how long they will last. Or that your doctor says your child has a temperature, but isn't sure how high. Quantitative ...
Nov 5, 2013
0
0
(Medical Xpress) -- In people and most animals, the nerves that carry electrical signals from one part of the body to another must have a protective coating (called a myelin sheath) to allow signals to travel properly. When ...
A team of investigators at Brigham and Women's Hospital (BWH) and the National Institute of Neurological Disorders and Stroke (NINDS) has launched a study of individuals at risk for multiple sclerosis (MS). By focusing on ...
Feb 8, 2016
0
46
Cognitive impairment is one of the core symptoms of multiple sclerosis (MS)—and one of its most troubling concerns for many people with the condition. Now, a new study from NYU Langone Medical Center may provide hope for ...
Apr 15, 2016
0
43